Ipca Laboratories Ltd. (IPCALAB): Ipca Laboratories Share Price Near 52-Week High as Stock Trades at Rs 2,000
- September 17, 2026
- Posted by: Harsh Piplani
- Category: News
Ipca Laboratories Share Price is trading at Rs 2,000, up Rs 36.75 or 1.87% from the previous close, and sits close to its 52-week high of Rs 2,003. The company’s market capitalisation stands at Rs 50,542.95 crore, placing the move in a large listed healthcare name within the pharmaceuticals and drugs industry. As of 24 September 2026 at 10:18 AM IST, the latest Univest data confirms the price is near its yearly high, which makes Ipca Laboratories Stock News relevant for readers tracking Ipca Laboratories Share Price Today and Ipca Laboratories Share Price Live. The verified data confirms the price event, while not establishing any company-specific catalyst. Univest is tracking the move alongside valuation and sector context.
The stock opened at Rs 1,971.45, moved between Rs 1,966.65 and Rs 2,003, and was last traded at Rs 2,000. That keeps Ipca Laboratories Share Price very close to the one-year high zone, with the gap to the 52-week peak now narrow in arithmetic terms. The turnover stood at Rs 1.28 crore. For readers scanning Ipca Laboratories Stock Analysis, the important point is straightforward: the quote is near the yearly high, the day’s range is tight, and the current price remains close to the top of the past year’s range. Univest flags this as a near-52-week-high event, not a record-high event.
Ipca Laboratories Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 2,000 |
| Previous Close | Rs 1,963.25 |
| Today's Move | +Rs 36.75 (+1.87%) |
| Open | Rs 1,971.45 |
| High | Rs 2,003 |
| Low | Rs 1,966.65 |
| Turnover | Rs 1.28 crore |
| Market Capitalisation | Rs 50,542.95 crore |
Ipca Laboratories Ltd. (IPCALAB) traded at Rs 2,000 versus the previous close of Rs 1,963.25, a rise of 1.87%. The stock opened at Rs 1,971.45, reached a high of Rs 2,003 and touched a low of Rs 1,966.65.
Ipca Laboratories Share Price Today is centred on a move from Rs 1,963.25 to Rs 2,000, which means the stock added Rs 36.75 during the trading morning. The day high of Rs 2,003 is just above the current quote, while the low of Rs 1,966.65 shows the stock has remained within a relatively narrow band so far. The open at Rs 1,971.45 left the price below the current level, and turnover of Rs 1.28 crore indicates the value of shares transacted in the market during the period observed. On a simple percentage basis, the stock is trading 1.87% higher than the previous close. That keeps Ipca Laboratories Share Price within touching distance of its 52 Week High and leaves the one-year high search interest intact for stock market today users. The next section shifts from price action to what the company’s financial ratios say.
Ipca Laboratories Ltd. (IPCALAB) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 50,542.95 crore |
| P/E Ratio | 38.03x |
| P/B Ratio | 5.87x |
| ROE | 15.88% |
| ROCE | 19.41% |
| EPS | Rs 51.63 |
| Book Value Per Share | Rs 334.38 |
| Dividend Yield | 0.31% |
Ipca Laboratories Ltd. (IPCALAB) fundamental metrics show P/E 38.03x, P/B 5.87x, ROE 15.88%, ROCE 19.41%. These figures provide context only and are not a buy or sell signal.
Ipca Laboratories Ltd. has a market capitalisation of Rs 50542.95 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 38.03x, P/B at 5.87x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 15.88% and ROCE of 19.41%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 51.63, book value per share of Rs 334.38, dividend yield of 0.31%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 28.31x, median ROE of 11.69%, median ROCE of 13.32%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 38.03x |
| Benchmark Median P/E | 28.31x |
| Benchmark Average P/E | 42.28x |
| Benchmark P/E Range | 0x to 762.66x |
| Company P/B Ratio | 5.87x |
| Benchmark Median P/B | 2.9x |
| Company ROE | 15.88% |
| Benchmark Median ROE | 11.69% |
| Company ROCE | 19.41% |
| Benchmark Median ROCE | 13.32% |
| Company Market Capitalisation | Rs 50,542.95 crore |
| Benchmark Median Market Cap | Rs 745.38 crore |
Ipca Laboratories Ltd. (IPCALAB) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.
Ipca Laboratories Ltd. (IPCALAB) has a P/E ratio of 38.03x, which is above the benchmark median of 28.31x, a difference of +34.33%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Ipca Laboratories Ltd. (IPCALAB) has a ROE of 15.88%, which is above the benchmark median of 11.69%, a difference of +35.84%. Ipca Laboratories Ltd. (IPCALAB) has a ROCE of 19.41%, which is above the benchmark median of 13.32%, a difference of +45.72%.
Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Anthem Biosciences Ltd. | ANTHEM | 50,252.61 | 86.29 | 15.88 | 21.98 | 29.62 |
| Glaxosmithkline Pharmaceuticals Ltd. | GLAXO | 48,644.94 | 45.62 | 19.33 | 48.76 | 66.79 |
| Gland Pharma Ltd. | GLAND | 48,132.02 | 42.51 | 4.51 | 10.56 | 14.96 |
| Abbott India Ltd. | ABBOTINDIA | 57,847.4 | 35.46 | 11.06 | 34.67 | 46.72 |
| Ajanta Pharma Ltd. | AJANTPHARM | 43,980.58 | 39.26 | 9.17 | 25.42 | 32.67 |
Ipca Laboratories Ltd. (IPCALAB) has a P/E ratio of 38.03x compared with the displayed peer median of 42.51x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 15.88% compares with a peer median of 25.42% across the companies shown in the table. ROCE stood at 19.41% versus the displayed peer median of 32.67%, providing a capital-efficiency comparison. Ipca Laboratories Ltd. (IPCALAB) has a market capitalisation of Rs 50,542.95 crore. Among the 5 peers shown, 1 has a larger market capitalisation.
Why Investors Are Watching Ipca Laboratories
- Ipca Laboratories Share Price is at Rs 2,000, close to the 52-week high of Rs 2,003.
- The stock is up 1.87% from the previous close of Rs 1,963.25.
- Market capitalisation stands at Rs 50,542.95 crore.
- PE is 38.03, PB is 5.87, ROE is 15.88% and ROCE is 19.41%.
- Revenue and profit for Jun 26 are above the Jun 25 figures.
About Ipca Laboratories
Ipca Laboratories Ltd. operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. The listed company is tracked on both NSE and BSE under the symbol IPCALAB. Its financial profile in the latest Univest data includes revenue, net profit, EPS, book value and return ratios, which makes Ipca Laboratories Share Price a useful case for readers who follow company financials and stock performance together. The business description in this article is intentionally limited to the verified sector and industry classification, in line with the latest Univest data set used for Ipca Laboratories Stock News and Ipca Laboratories Share News monitoring.
Frequently Asked Questions
Why is Ipca Laboratories Share Price near its 52-week high?
Ans. Ipca Laboratories Share Price is at Rs 2,000, just below its 52-week high of Rs 2,003. The move is visible in the price data, while the article does not assign a company-specific trigger.
What is Ipca Laboratories Share Price today?
Ans. Ipca Laboratories Share Price today is Rs 2,000, which is Rs 36.75 above the previous close of Rs 1,963.25. The stock is trading 1.87% higher in the latest session data.
What does Ipca Laboratories market cap show?
Ans. Ipca Laboratories has a market capitalisation of Rs 50,542.95 crore. That places it well above the industry median in the same-industry benchmark set and gives useful size context for valuation reading.
How does Ipca Laboratories compare on valuation?
Ans. Ipca Laboratories trades at a P/E of 38.03 and P/B of 5.87. Both are above the industry medians of 28.31 and 2.9, so the stock is valued above the benchmark centre.
What do Ipca Laboratories ROE and ROCE indicate?
Ans. Ipca Laboratories reports ROE of 15.88% and ROCE of 19.41%. Both are above the same-industry medians, which helps place its return ratios in a stronger position than the industry midpoint.
What is Ipca Laboratories EPS and book value?
Ans. EPS is Rs 51.63 and book value per share is Rs 334.38. EPS reflects earnings attributable to each share, while book value shows the accounting net worth behind each share.
What is Ipca Laboratories dividend yield?
Ans. Ipca Laboratories dividend yield is 0.31%. That is a historical current-yield measure and should be read alongside price, valuation and earnings rather than as a guaranteed payout signal.
What sector does Ipca Laboratories belong to?
Ans. Ipca Laboratories belongs to the Healthcare sector and the Pharmaceuticals & Drugs industry. The same-industry benchmark covers 199 companies, which makes the peer and valuation context broad enough for comparison.
Track Ipca Laboratories Share Price on Univest
Use Ipca Laboratories Ltd. (IPCALAB) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.
You can track Ipca Laboratories Share Price on Univest for live price updates, 52-week levels, valuation ratios, company financials, sector context and peer comparison. Univest also brings together Ipca Laboratories Share Price Today, Ipca Laboratories Latest News and Ipca Laboratories Stock Analysis in one place for quick market review.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).